Access & Product Management

Photo: Alena Koscalove/MSF

Products & projects

MMV strongly believes that all malaria patients, rich or poor, deserve the best and safest treatment possible. 

To deliver their life-saving impact, highly effective antimalarials should be accessible to sick, vulnerable patients within the first 24 hours of symptom onset. By advancing access to these medicines, we are working with our partners towards the day when no one in world will suffer or die from malaria.